Calming gel could ease agony of dementia care battles
NCT ID NCT06638710
Summary
This study is testing whether a fast-acting, oral calming medication (midazolam gel) can help elderly patients with moderate to severe dementia accept essential medical care, like bathing or wound dressing, when they are agitated and refusing it. It aims to see if this approach is safer and easier than an injection. The trial will involve 30 hospitalized patients or those in long-term care facilities.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROCOGNITIVE DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Geriatric department of Grenoble Alpes university hospital
RECRUITINGGrenoble, Isere, 38043, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.